Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease.

Sontake V, Kasam RK, Sinner D, Korfhagen TR, Reddy GB, White ES, Jegga AG, Madala SK.

JCI Insight. 2018 Aug 23;3(16). pii: 121252. doi: 10.1172/jci.insight.121252. [Epub ahead of print]

2.

Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis.

Karki S, Surolia R, Hock TD, Guroji P, Zolak JS, Duggal R, Ye T, Thannickal VJ, Antony VB.

FASEB J. 2014 Mar;28(3):1122-31. doi: 10.1096/fj.13-236828. Epub 2013 Nov 21.

3.

Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.

Sontake V, Shanmukhappa SK, DiPasquale BA, Reddy GB, Medvedovic M, Hardie WD, White ES, Madala SK.

J Immunol. 2015 Oct 15;195(8):3978-91. doi: 10.4049/jimmunol.1500963. Epub 2015 Sep 14.

4.

Hsp90 regulation of fibroblast activation in pulmonary fibrosis.

Sontake V, Wang Y, Kasam RK, Sinner D, Reddy GB, Naren AP, McCormack FX, White ES, Jegga AG, Madala SK.

JCI Insight. 2017 Feb 23;2(4):e91454. doi: 10.1172/jci.insight.91454.

5.

Pulmonary fibrosis requires cell-autonomous mesenchymal fibroblast growth factor (FGF) signaling.

Guzy RD, Li L, Smith C, Dorry SJ, Koo HY, Chen L, Ornitz DM.

J Biol Chem. 2017 Jun 23;292(25):10364-10378. doi: 10.1074/jbc.M117.791764. Epub 2017 May 9.

6.

The pleural mesothelium in development and disease.

Batra H, Antony VB.

Front Physiol. 2014 Aug 1;5:284. doi: 10.3389/fphys.2014.00284. eCollection 2014.

7.

Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.

Estany S, Vicens-Zygmunt V, Llatjós R, Montes A, Penín R, Escobar I, Xaubet A, Santos S, Manresa F, Dorca J, Molina-Molina M.

BMC Pulm Med. 2014 Jul 26;14:120. doi: 10.1186/1471-2466-14-120.

8.

Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease.

Braitsch CM, Kanisicak O, van Berlo JH, Molkentin JD, Yutzey KE.

J Mol Cell Cardiol. 2013 Dec;65:108-19. doi: 10.1016/j.yjmcc.2013.10.005. Epub 2013 Oct 17.

9.

Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.

Machahua C, Montes-Worboys A, Llatjos R, Escobar I, Dorca J, Molina-Molina M, Vicens-Zygmunt V.

Respir Res. 2016 Nov 5;17(1):144.

10.

The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.

Bagchi RA, Roche P, Aroutiounova N, Espira L, Abrenica B, Schweitzer R, Czubryt MP.

BMC Biol. 2016 Mar 17;14:21. doi: 10.1186/s12915-016-0243-8.

11.

Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis.

Inoue Y, King TE Jr, Barker E, Daniloff E, Newman LS.

Am J Respir Crit Care Med. 2002 Sep 1;166(5):765-73.

PMID:
12204879
12.

Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.

Roach KM, Wulff H, Feghali-Bostwick C, Amrani Y, Bradding P.

Respir Res. 2014 Dec 5;15:155. doi: 10.1186/s12931-014-0155-5.

13.

Wt1-expressing progenitors contribute to multiple tissues in the developing lung.

Cano E, Carmona R, Muñoz-Chápuli R.

Am J Physiol Lung Cell Mol Physiol. 2013 Aug 15;305(4):L322-32. doi: 10.1152/ajplung.00424.2012. Epub 2013 Jun 28.

14.

Origin and characterization of alpha smooth muscle actin-positive cells during murine lung development.

Moiseenko A, Kheirollahi V, Chao CM, Ahmadvand N, Quantius J, Wilhelm J, Herold S, Ahlbrecht K, Morty RE, Rizvanov AA, Minoo P, El Agha E, Bellusci S.

Stem Cells. 2017 Jun;35(6):1566-1578. doi: 10.1002/stem.2615. Epub 2017 Apr 3.

15.

Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.

Tumelty KE, Smith BD, Nugent MA, Layne MD.

J Biol Chem. 2014 Jan 31;289(5):2526-36. doi: 10.1074/jbc.M113.502617. Epub 2013 Dec 16.

16.

Novel Differences in Gene Expression and Functional Capabilities of Myofibroblast Populations in Idiopathic Pulmonary Fibrosis.

Walsh SM, Worrell JC, Fabre A, Hinz B, Kane R, Keane MP.

Am J Physiol Lung Cell Mol Physiol. 2018 Aug 9. doi: 10.1152/ajplung.00543.2017. [Epub ahead of print]

PMID:
30091381
17.

MK2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis.

Liang J, Liu N, Liu X, Monterrosa Mena J, Xie T, Geng Y, Huan C, Zhang Y, Taghavifar F, Huang G, Kurkciyan A, Barron V, Jiang D, Noble PW.

Am J Respir Cell Mol Biol. 2018 Aug 21. doi: 10.1165/rcmb.2018-0033OC. [Epub ahead of print]

PMID:
30130411
18.

Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A.

Szemes M, Dallosso AR, Melegh Z, Curry T, Li Y, Rivers C, Uney J, Mägdefrau AS, Schwiderski K, Park JH, Brown KW, Shandilya J, Roberts SG, Malik K.

Hum Mol Genet. 2013 Jan 1;22(1):74-83. doi: 10.1093/hmg/dds403. Epub 2012 Oct 5.

PMID:
23042785
19.

Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury.

Zolak JS, Jagirdar R, Surolia R, Karki S, Oliva O, Hock T, Guroji P, Ding Q, Liu RM, Bolisetty S, Agarwal A, Thannickal VJ, Antony VB.

Am J Pathol. 2013 Apr;182(4):1239-47. doi: 10.1016/j.ajpath.2012.12.030. Epub 2013 Feb 9.

20.

FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.

Joannes A, Brayer S, Besnard V, Marchal-Sommé J, Jaillet M, Mordant P, Mal H, Borie R, Crestani B, Mailleux AA.

Am J Physiol Lung Cell Mol Physiol. 2016 Apr 1;310(7):L615-29. doi: 10.1152/ajplung.00185.2015. Epub 2016 Jan 15.

Supplemental Content

Support Center